Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-23-000261
Accepted
2023-02-03 00:15:14
Documents
1
Effectiveness Date
2023-02-02
Registration Form
S-1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 594
  Complete submission text file 9999999995-23-000261.txt   2030
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-269363 | Film No.: 23583595
SIC: 2834 Pharmaceutical Preparations